Mycotopia Therapies Inc (TPIA)
0.058
+0.02
(+45.00%)
USD |
OTCM |
May 28, 16:00
Mycotopia Therapies Enterprise Value: 1.759M for May 28, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 28, 2024 | 1.759M |
| May 24, 2024 | 1.490M |
| May 23, 2024 | 1.490M |
| May 22, 2024 | 1.490M |
| May 21, 2024 | 1.282M |
| May 20, 2024 | 1.490M |
| May 17, 2024 | 1.490M |
| May 16, 2024 | 1.342M |
| May 15, 2024 | 1.610M |
| May 14, 2024 | 1.610M |
| May 13, 2024 | 1.580M |
| May 10, 2024 | 1.580M |
| May 09, 2024 | 1.580M |
| May 08, 2024 | 1.580M |
| May 07, 2024 | 1.580M |
| May 06, 2024 | 1.580M |
| May 03, 2024 | 1.580M |
| May 02, 2024 | 1.788M |
| May 01, 2024 | 1.788M |
| April 30, 2024 | 1.788M |
| April 29, 2024 | 1.788M |
| April 26, 2024 | 1.493M |
| April 25, 2024 | 1.495M |
| April 24, 2024 | 1.759M |
| April 23, 2024 | 1.759M |
| Date | Value |
|---|---|
| April 22, 2024 | 1.565M |
| April 19, 2024 | 1.966M |
| April 18, 2024 | 1.966M |
| April 17, 2024 | 2.029M |
| April 16, 2024 | 2.029M |
| April 15, 2024 | 1.958M |
| April 12, 2024 | 2.380M |
| April 11, 2024 | 2.381M |
| April 10, 2024 | 2.072M |
| April 09, 2024 | 2.992M |
| April 08, 2024 | 2.992M |
| April 05, 2024 | 2.962M |
| April 04, 2024 | 2.962M |
| April 03, 2024 | 2.935M |
| April 02, 2024 | 2.608M |
| April 01, 2024 | 3.055M |
| March 28, 2024 | 2.599M |
| March 27, 2024 | 2.760M |
| March 26, 2024 | 2.376M |
| March 25, 2024 | 2.599M |
| March 22, 2024 | 2.674M |
| March 21, 2024 | 2.748M |
| March 20, 2024 | 2.301M |
| March 19, 2024 | 1.944M |
| March 18, 2024 | 2.152M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
0.5654M
Minimum
Jun 26 2020
109.62M
Maximum
Mar 10 2021
15.47M
Average
2.992M
Median
Apr 08 2024
Enterprise Value Benchmarks
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.4259M |
| Total Expenses (Quarterly) | 0.3609M |
| EPS Diluted (Quarterly) | -0.03 |
| Earnings Yield | -155.2% |